English 中文

ASE’s update on COVID-19

As of Feb 10, 2020, all our China offices have re-opened and resumed operation. We will continue to implement strict measures at all ASE facilities worldwide (including employee housing estates) and comply with local government health and safety regulations closely, to combat the spread of COVID-19 and protect our employees and customers.

We are faced with various types of disruptions each day, but ASE is fortunate to be able to leverage on the resources across all sites to mitigate the impact. The COVID-19 situation is still evolving and we will disclose relevant information as soon as reasonably possible.

Should you have any further questions or concerns, please contact your respective Sales personnel, or email jennifer.yuen@aseus.com.

ASE Shanghai - A&T
ASE Shanghai - Material
ASE Kunshan
ASE Suzhou
ASE Weihai
ASE Wuxi
ASE Kaohsiung
ASE Chungli
ASE Korea
ASE Malaysia
ASE Singapore

Related Resources

Video in Chinese. Dr Zhong Nanshan is a Chinese pulmonologist who discovered the SARS coronavirus in 2003. He was president of the Chinese Medical Association from 2005 to 2009 and is currently the editor-in-chief of the Journal of Thoracic Disease. He is most well known for managing the SARS outbreak in Guangdong province in 2003.

About The ASE Group

The ASE Group is among the leading providers of independent semiconductor manufacturing services in assembly, test, materials and design manufacturing. As a global leader geared towards meeting the industry’s ever growing needs for faster, smaller and higher performance chips, the Group develops and offers a wide portfolio of technology and solutions including IC test program design, front-end engineering test, wafer probe, wafer bump, substrate design and supply, wafer level package, flip chip, system-in-package, final test and electronic manufacturing services through Universal Scientific Industrial Co., Ltd. and its subsidiaries, members of the ASE Group. For more information about the ASE Group, visit www.aseglobal.com.